|
Rheumatoid Arthritis
Citations 551-560 of 841 total displayed.
|
Past content
(since Feb 2000):
|
- CLINICAL
The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions
- A. J. Kinder, A. B. Hassell, J. Brand, A. Brownfield, M. Grove, and M. F. Shadforth
Rheumatology 2005; 44: 61-66.
[Abstract]
[Full Text]
- CLINICAL
Rheumatology patient preferences for timing and location of out-patient clinics
- K. M. J. Douglas, T. Potter, G. J. Treharne, K. Obrenovic, E. D. Hale, A. Pace, D. Mitton, N. Erb, A. Whallett, J. P. Delamere, and G. D. Kitas
Rheumatology 2005; 44: 80-82.
[Abstract]
[Full Text]
- CLINICAL
Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients
- M. Ahlmén, U. Nordenskiöld, B. Archenholtz, I. Thyberg, R. Rönnqvist, L. Lindén, A.-K. Andersson, and K. Mannerkorpi
Rheumatology 2005; 44: 105-110.
[Abstract]
[Full Text]
- CLINICAL
Relationship between growth hormone–IGF-I–IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis
- É. Toussirot, N. U. Nguyen, G. Dumoulin, F. Aubin, J.-P. Cédoz, and D. Wendling
Rheumatology 2005; 44: 120-125.
[Abstract]
[Full Text]
- CASE REPORTS
Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy
- C. Rodriguez-Escalera, J. Belzunegui, L. Lopez-Dominguez, C. Gonzalez, and M. Figueroa
Rheumatology 2005; 44: 132-133.
[Extract]
[Full Text]
- MATTERS ARISING
How aggressive should initial therapy for rheumatoid arthritis be?
- T. Pincus and T. Sokka
Rheumatology 2005; 44: 133-134.
[Extract]
[Full Text]
- MATTERS ARISING
How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience
- K. Kaarela, M. Hakala, P. Hannonen, H. Kautiainen, M. Korpela, M. Leirisalo-Repo, R. Luosujärvi, R. Luukkainen, T. Möttönen, and K. Puolakka
Rheumatology 2005; 44: 134-135.
[Extract]
[Full Text]
- MATTERS ARISING
How aggressive should initial therapy for rheumatoid arthritis be? Reply
- E. L. Matteson, C. M. Weyand, and J. G. Goronzy
Rheumatology 2005; 44: 135-136.
[Extract]
[Full Text]
- EDITORIALS
BSR Biologics Registry
- I. Griffiths, A. Silman, D. Symmons, and D. G. I. Scott
Rheumatology 2004; 43: 1463-1464.
[Extract]
[Full Text]
- EDITORIALS
The measure of our measures
- M. Harth and J. Pope
Rheumatology 2004; 43: 1465-1467.
[Extract]
[Full Text]
|
|
